Arax Advisory Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2K	Sell	55 -23	-29%	-$836	﹤0.01%	2564
2025 Q1	$2.83K	Sell	78 -47	-38%	-$1.7K	﹤0.01%	1970
2024 Q4	$5.26K	Buy	125 +3	+2%	+$126	﹤0.01%	1724
2024 Q3	$6.78K	Buy	122 +22	+22%	+$1.22K	﹤0.01%	1576
2024 Q2	$4.11K	Buy	+100	New	+$4.11K	﹤0.01%	1679